These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20364695)

  • 1. [The clinical efficiency and safety of iodide-bromine balneotherapy in patients with coronary heart disease concurrent with chronic obstructive pulmonary disease].
    Zunnunov ZR
    Ter Arkh; 2010; 82(1):24-7. PubMed ID: 20364695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathogenetic features of coronary heart disease combined with chronic obstructive pulmonary diseases and efficiency of therapy with trimetazidin].
    Kolomoets NM; Baksheev VI; Uvaĭsova KU
    Klin Med (Mosk); 2008; 86(6):38-43. PubMed ID: 18720710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of a cardioselective beta1-adrenoblocker bisoprolol in patients with chronic obstructive pulmonary disease in combination with ischemic heart disease].
    Tsvetkova OA; Veselovskaia MV
    Ter Arkh; 2007; 79(3):25-9. PubMed ID: 17526191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aortic stiffness in chronic obstructive pulmonary disease concurrent with ischemic heart disease].
    Nevzorova VA; Shekunova OI; Brodskaia TA
    Ter Arkh; 2010; 82(3):18-22. PubMed ID: 20564915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of iodobromide baths on the physical work capacity and extrasystole in patients with ischemic heart disease and stable stenocardia].
    Klemenko SV; Davydova OB; Makarkin AS; Klemenkova ZhE
    Vopr Kurortol Fizioter Lech Fiz Kult; 1995; (6):11-4. PubMed ID: 8713298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicofunctional characteristics of the heart in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease].
    Borovkov NN; Grigor'eva NIu
    Ter Arkh; 2006; 78(12):24-7. PubMed ID: 17294859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heart rhythm disturbances in patients with chronic obstructive pulmonary disease in aggregate with coronary heart disease].
    Shoĭkhet IaN; Klester EB; Golovin VA
    Klin Med (Mosk); 2008; 86(3):21-6. PubMed ID: 18441699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of hydrogen sulfide balneotherapy in ischemic heart disease the arid zone].
    Zunnunov ZR
    Ter Arkh; 2004; 76(8):15-8. PubMed ID: 15471388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endothelial dysfunction in patients with combined coronary heart disease and chronic obstructive pulmonary disease].
    Grigor'eva NIu; Sharabrin EG; Kontorshchikova KN; Kuznetsov AN; Mazalov KV; Koroleva EF
    Klin Med (Mosk); 2009; 87(8):41-4. PubMed ID: 19827529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of the I(f) channel blocker ivabradine on the parameters of external respiration function in patients with chronic obstructive pulmonary disease in its stable course period].
    Komlev AD; Kuziaev AI; Laskin GM; Kuzenkova VE; Kolosova MV
    Ter Arkh; 2010; 82(3):23-5. PubMed ID: 20564916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of meloxicam (movalis) in patients with rheumatic diseases with concomitant coronary heart disease].
    Mazurov VI; Iakusheva VA; Beliaeva IB
    Klin Med (Mosk); 2004; 82(12):54-9. PubMed ID: 15732722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and diagnostic significance of intima-media thickness in chronic obstructive pulmonary disease].
    Akramova ÉG
    Ter Arkh; 2013; 85(12):36-40. PubMed ID: 24640665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Digestive system pathology in patients with chronic obstructive pulmonary disease concurrent with coronary heart disease].
    Shoĭkhet IaN; Klester EB
    Ter Arkh; 2010; 82(2):25-8. PubMed ID: 20387671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intracardiac hemodynamics in patients with isolated chronic obstructive pulmonary disease and coronary heart disease].
    Nevzorova VA; Golotina OV; Kochetkova EA; Ponomarenko IuV; Kessler R; Massard J
    Klin Med (Mosk); 2010; 88(1):37-41. PubMed ID: 20369610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chronic obstructive pulmonary diseases on outcomes and hospital days after percutaneous coronary intervention.
    Zhang JW; Zhou YJ; Yang Q; Yang SW; Nie B; Xu XH
    Angiology; 2013 Aug; 64(6):430-4. PubMed ID: 22942128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical markers of endothelial dysfunction in chronic obstructive pulmonary disease concurrent with hypertensive disease or coronary heart disease].
    Akhmineeva AKh
    Ter Arkh; 2014; 86(3):20-3. PubMed ID: 24779065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Manifestations of painless myocardial ischemia in patients with chronic obstructive pulmonary disease].
    Pavlenko VI; Naryshkina SV
    Kardiologiia; 2012; 52(2):36-40. PubMed ID: 22792737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pilot experience in Russia with external contrapulsation in patients with coronary heart disease].
    Gabrusenko SA; Malakhov VV; Sergienko IV; Naumov VG; Belenkov IuN
    Ter Arkh; 2006; 78(9):27-33. PubMed ID: 17076221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of therapy with bisoprolol and ivabradine in patients with ischemic heart disease combined with chronic obstructive pulmonary disease assessment of parameters of 24-hour ECG monitoring].
    Grigor'eva NIu
    Kardiologiia; 2009; 49(7-8):38-41. PubMed ID: 19656105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of combined application of nitrogen baths and 6 month physical training on physical work capacity and extrasystole in patients with ischemic heart disease and stable stenocardia].
    Klemenkov SV; Razumov AN; Iavisia AM; Voronin SS; Kubushko IV
    Ter Arkh; 2003; 75(12):23-6. PubMed ID: 14959464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.